Literature DB >> 26922687

Clinically unrecognized miliary tuberculosis: an autopsy study.

Ivana Savic1, Vesna Trifunovic-Skodric, Dragan Mitrovic.   

Abstract

BACKGROUND: Miliary tuberculosis (TB) usually presents with atypical clinical manifestations; thus it is often recognized only at autopsy.
OBJECTIVES: Our objectives were to study the frequency of MT diagnosed at autopsy and determine clinical diagnoses that masked TB, as well as causes of death and comorbidities.
DESIGN: Retrospective study of all autopsies performed between 2008 and 2014.
SETTING: Institute of Pathology, Belgrade, Serbia. SUBJECTS AND METHODS: in subjects where autopsy showed the presence of MT that was not recognized clinically, we recorded the clinical diagnoses (presumed causes of death) as reported in autopsy request forms, as well as actual cause of death and comorbidities as determined at autopsy. MAIN OUTCOME MEASURES: Clinically unrecognized MT.
RESULTS: The total number of autopsies in this period was 6206. thirty-five individuals showed clinically unrecognized MT (0.56% of all autopsies, age: 62.2 [17.2] years, M:F=2:3). Common clinical diagnoses masking pulmonary MT were exacerbation of COPD (25%) and pulmonary thromboembolism (25%), with common radiological presentation of diffuse pulmonary infiltrates (56.3%). Dominant clinical diagnoses in patients with generalized MT were adult respiratory distress syndrome, sepsis, gastrointestinal bleeding and meningoencephalitis. Disseminated MT was often associated with secondary anemia or thrombocytopenia (15.8%) and recent surgery (15.8%). Frequent comorbidities included chronic renal failure and malignancies, whereas MT was a dominant cause of death.
CONCLUSION: Greater awareness of MT is needed to improve recognition in clinical settings. In particular, MT should be considered in patients with atypical clinical presentation and diffuse pulmonary infiltrates on chest X-ray, particularly if they have chronic renal failure, malignancy, hematological disorders or a history of recent surgery. LIMITATIONS: None.

Entities:  

Mesh:

Year:  2016        PMID: 26922687      PMCID: PMC6074281          DOI: 10.5144/0256-4947.2016.42

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


Tuberculosis (TB) is a chronic infectious disease that represents an important cause of death in undeveloped and developing countries. According to the latest WHO data, 9 million people acquired TB and 1.5 million died in 2013 worldwide.1 Countries with immigrants and workers from TB endemic countries face an increasing TB burden even though the incidence may have been decreasing.2 For instance, in the period between 1991 and 2010 in Saudi Arabia, the annual TB rate was in the range 8.6–12.2 per 100 000 persons for the original Saudi population, while non-Saudis had 2 to 3 times higher incidence.2 The incidence of TB in Serbia has been declining since 1990 and current data of the national Institute of Public Health in Belgrade report the actual incidence rate for TB to be 15.61 per 100 000 persons.3 Efforts are underway to control the disease, but new strategies are necessary to eliminate it at a global level.4 TB is caused by the human type of Mycobacterium tuberculosis, which is usually transmitted via inhalation of infective droplets. Reservoirs of infection are usually people with the active pulmonary form of TB. Classification of TB is based on characteristics of its development and course, and encompassing primary, postprimary or secondary, and miliary TB. Miliary TB is a complication occurring either during primary or postprimary TB when M tuberculosis gets into the bloodstream and is disseminated within the lungs or other organs.5 Even in 1700, John Jacob Manget described disseminated TB as numerous small nodules in lung parenchyma, and termed it “miliary tuberculosis” (lat. “millet”, grain of millet) and suggested it was a fatal form of the disease.6 Although the incidence of TB is declining, miliary TB still displays a notable and stable incidence. If not recognized and treated in time, miliary TB is potentially lethal.5 Unfortunately, diagnosis of miliary TB can be complicated even for the most experienced clinicians. Given that it has an atypical clinical presentation and can resemble many other diseases, diagnosis of miliary TB is often made at autopsy. Miliary TB can manifest acutely as multiorgan dysfunction,7 septic shock syndrome8 or as adult respiratory distress syndrome.9,10 Patients with more chronic form of disease can show a delay in growth and development,11 fever of unknown origin12 or dysfunction of one or more organs.13 Predisposing factors and conditions associated with development of miliary TB are malnutrition, HIV infection, diabetes mellitus, chronic renal failure, dialysis, organ transplantation, malignant tumors, and silicosis.5 However, the pathogenetic mechanism is not clear. Given the great importance of clinically unrecognized forms of TB both in specialized lung hospitals and in general hospitals,14 the aim of this study was to analyze autopsy cases of clinically unrecognized cases of miliary TB, to determine the clinical diagnoses that most frequently mask the TB, as well as comorbidities that contibute to development and a lethal outcome.

SUBJECTS AND METHODS

This was a retrospective study of all autopsy protocols and reports conducted at the Institute of Pathology, Faculty of Medicine, University of Belgrade in a 7-year period (January 1st 2008-December 31st 2014). Autopsy request forms (the forms that had been sent to the Institute of Pathology by the clinicians to require autopsy of the deceased patient) were analyzed. From these forms, we recorded patient sex and age, and the main clinical diagnoses, i.e., presumed causes of death of each individual as reported by the responsible clinicians. In addition, we noted the type of hospital (general hospitals vs. specialized pulmonary hospitals) from which the deceased were sent to the Institute of Pathology for autopsy. Based on the information from autopsy request forms as well as autopsy findings, the study group was composed of autopsied individuals with no mention of clinical diagnosis of TB or antemortem suspicion of TB, but in whom the miliary TB was ascertained at autopsy. These individuals were referred to as “clinically unrecognized TB”. They were classified based on autopsy diagnosis to those with miliary pulmonary TB and those with miliary generalized (disseminated) TB. In the individuals with miliary generalized form of TB, we recorded the distribution of TB granulomas throughout the body. TB granulomas were recognized as small whitish nodular formations with typical histological features of agglomeration of epitheloid cells, giant cells of Langhans type and lymphocytes, with centrally located caseous necrosis (Figure 1). Based on autopsy findings, the actual causes of death were noted, as well as main comorbidities.
Figure 1

a) Histopathological findings of tuberculous granuloma in lung parenchyma (H&E staining, ×40) (Asterisk denotes the area of caseous necrosis, and the black arrow points to a giant cell of Langhans); b) Histopathological findings of numerous tuberculous granulomas in bone marrow of the autopsied individual with clinical diagnosis of thrombocytopenia and rectorrhage (H&E staining, ×100).”

Statistical analysis was performed with the software package SPSS v.15.0 (SPSS Inc. Chicago, IL). Differences were considered significant if the P value was less than .05. Chi square or the t test were applied for comparisons.

RESULTS

The number of autopsies in the reported 7-year-period was 6206, of which 35 (0.56%) were of individuals with clinically unrecognized miliary TB. Of these, 16 autopsied individuals (45.7%) had miliary pulmonary TB, while 19 individuals (54.3%) had miliary disseminated TB. Mean age of the individuals expressing miliary TB was 62.2 (17.2) years. Females predominated (n=21, 60%) over males (n=14, 40%). Mean age (standard deviation) was 56.5 (16.8) years in men and 66.1 (16.9) in women (P=.11). Fewer autopsied persons with clinically unrecognized miliary TB were sent from specialized pulmonary clinics (n=12, 34.29%) in comparison with deceased patients (n=23, 65.71%) sent from general hospitals (P=.06). The mean age of individuals with unrecognized miliary TB who died in specialized pulmonary clinics was 66.2 (4.1) years, while the mean age of those who died in general hospitals was 60.6 (3.9) (P=.46). Correlation of autopsy findings with the data from autopsy request forms filled out by clinicians revealed a number of diseases for which TB was mistaken (i.e., diagnoses that “masked” the actual TB). Most common clinical diagnoses that had been reported in the autopsy request forms for the individuals in whom miliary pulmonary TB was discovered in autopsy material were chronic obstructive pulmonary disease in exacerbation (25%) and pulmonary thromboembolism (25%) (Table 1a, b, c).
Table 1a

Clinical diagnoses (presumed causes of death) as reported in autopsy request forms, in individuals where autopsy showed miliary pulmonary tuberculosis: sex distribution.

Clinical diagnosesNPercentage (%)
MaleFemaleTotal

Chronic obstructive pulmonary disease in exacerbation13425
Pulmonary thromboembolism13425
Pleural effusion30318.75
Bronchopneumonia02212.5
Pulmonary edema02212.5
Status febrilis0116.25
Total51116100
Table 1b

Clinical diagnoses (presumed causes of death) as reported in autopsy request forms, in the individuals where autopsy showed miliary pulmonary tuberculosis: age distribution.

Clinical diagnosesAge (years)Total
<4040–5960–79≥80

Chronic obstructive pulmonary disease in exacerbation00224
Pulmonary thromboembolism01304
Pleural effusion00213
Bronchopneumonia00112
Pulmonary edema01012
Status febrilis00011
Table 1c

Clinical diagnoses (presumed causes of death) as reported in autopsy request forms, in the individuals where autopsy showed miliary pulmonary tuberculosis: distribution by year.

Clinical diagnosesYearTotal
2008200920102011201220132014

Chronic obstructive pulmonary disease in exacerbation01012004
Pulmonary thromboembolism01011104
Pleural effusion01011003
Bronchopneumonia00002002
Pulmonary edema00200002
Status febrilis00100001
Most frequent clinical diagnoses reported in the autopsy request forms for the individuals with miliary disseminated TB revealed on autopsy were sepsis (10.52%), adult respiratory distress syndrome (ARDS) (10.52%), gastrointestinal bleeding (10.52%) and meningoencephalitis (10.52%) (Table 2a, b, c).
Table 2a

Clinical diagnoses (presumed causes of death) as reported in autopsy request forms, in the individuals where autopsy showed miliary disseminated tuberculosis: sex distribution.

Clinical diagnosesNPercentage (%)
MaleFemaleTotal

Sepsis11210.52
ARDS11210.52
Gastrointestinal bleeding11210.52
Meningoencephalitis11210.52
Suspected metastatic deposits in lung parenchyma1015.26
Suspected metastatic deposits in liver0115.26
Bronchial hemorrhage with suffocation0115.26
Status febrilis0115.26
Crohn’s disease0115.26
Ileus0115.26
Syndroma Moszkowicz0115.26
Hydrocephalus1015.26
Respiratory failure21315.84
Total81119100
Table 2b

Clinical diagnoses (presumed causes of death) as reported in autopsy request forms, in the individuals where autopsy showed miliary disseminated tuberculosis: age distribution

Clinical diagnosesAge (years)Total
<4040–5960–79≥80

Sepsis01102
ARDS11002
Gastrointestinal bleeding00112
Meningoencephalitis01102
Suspected metastatic deposits in lung parenchyma00101
Suspected metastatic deposits in liver00101
Bronchial hemorrhage with suffocation00101
Status febrilis00101
Crohn’s disease01001
Ileus00101
Syndroma Moszkowicz10001
Hydrocephalus10001
Respiratory failure00303
Table 2c

Clinical diagnoses (presumed causes of death) as reported in autopsy request forms, in the individuals where autopsy showed miliary disseminated tuberculosis: distribution by year.

Clinical diagnosesYearTotal
2008200920102011201220132014

Sepsis00020002
ARDS00020002
Gastrointestinal bleeding00100102
Meningoencephalitis00101002
Suspected metastatic deposits in lung parenchyma10000001
Suspected metastatic deposits in liver00001001
Bronchial hemorrhage with suffocation00001001
Status febrilis00010001
Crohn’s disease00010001
Ileus00100001
Syndroma Moszkowicz01000001
Hydrocephalus00000101
Respiratory failure00011103
Based on the information from autopsy request forms, chest X-ray showed diffuse pulmonary infiltrates in 56.3% of individuals with miliary pulmonary TB and 21.1% of those with miliary disseminated TB. Hematological abnormalities (secondary anemia, thrombocytopenia) dominated in three cases of miliary disseminated TB (15.8%). Moreover, three patients (15.8%) with postmortem diagnosed miliary disseminated TB had been subjected to recent surgery for kidney transplantation, hysterectomy with adnexectomy, and intestinal subocclusion. Table 3 shows actual causes of death in all individuals with clinically unrecognized miliary TB according to sex, age and year of the study (Table 3a, b, c). The autopsied individuals with miliary TB mostly died of miliary pulmonary TB (n=9, 25.7%), miliary disseminated TB (n=8, 22.9%), acute myocardial infarction (n=4, 11.4%) and bronchopneumonia (n=4, 11.4%) (Table 3a, b, c). When separately analyzing the individuals with miliary pulmonary TB, it was obvious that they mostly died of miliary pulmonary TB (n=9, 56.25%), followed by myocardial infarction (n=4, 25%), pseudomembranous colitis (n=2, 12.5%) and pulmonary thromboembolism (n=1, 6.25%). The autopsied individuals with pathological findings of miliary disseminated TB mostly died of miliary TB (n=8, 42.11%), followed by bronchopneumonia (n=4, 21.05%), ARDS (n=3, 15.79%), tuberculous meningoencephalitis (n=3, 15.79%) and pulmonary thromboembolism (n=1, 5.26%).
Table 3a

Causes of death as determined during autopsy: sex distribution.

Causes of deathNPercentage (%)
MalesFemalesTotal

Miliary pulmonary tuberculosis45925.7
Miliary disseminated tuberculosis17822.9
Adult respiratory distress syndrome (ARDS)2138.6
Bronchopneumonia22411.4
Pseudomembranous colitis1125.7
Tuberculous meningoencephalitis3038.6
Acute myocardial infarction13411.4
Pulmonary thromboembolism0225.7
Total142135100
Table 3b

Causes of death as determined during autopsy: age distribution.

Cause of deathAge (years)Total
<4040–5960–79≥80

Miliary pulmonary tuberculosis03339
Miliary disseminated tuberculosis01618
Adult respiratory distress syndrome (ARDS)10203
Bronchopneumonia21014
Pseudomembranous colitis00202
Tuberculous meningoencephalitis11103
Acute myocardial infarction11114
Pulmonary thromboembolism00112
Table 3c

Causes of death as determined during autopsy: distribution by year.

Causes of deathYearTotal
2008200920102011201220132014

Miliary pulmonary tuberculosis12212109
Miliary disseminated tuberculosis00232108
Adult respiratory distress syndrome10010103
Bronchopneumonia01011104
Pseudomembranous colitis00002002
Tuberculous meningoencephalitis00110103
Acute myocardial infarction12000104
Pulmonary thromboembolism00110002
Extrapulmonary granulomas in miliary disseminated TB were most commonly found in the liver (68.4%), the spleen (63.2%) and kidneys (42.1%) (Table 4a, b, c; Figure 1b). In all cases of miliary pulmonary and miliary disseminated TB, the lungs were affected by disseminated granulomas. The most frequent comorbidities in patients with miliary pulmonary TB and miliary disseminated TB were hypertensive heart disease (17.1%), chronic renal failure (11.4%), malignancies (11.4%), diabetes mellitus type 2 (8.6%), alcoholism (2.9%) and liver cirrhosis (2.9%).
Table 4a

Distribution of TB granulomas in patients with disseminated miliary TB, according to sex.

OrganNPercentage* (%)
MalesFemalesTotal

Lungs81119100
Liver491368.42
Spleen481263.15
Kidney44842.10
Adrenal glands22421.05
Bone marrow22421.05
Brain30315.78
Small and large intestines13421.05
Prostate1015.26
Urinary bladder0115.26
Ovary0115.26
Fallopian tube0115.26
Uterus0115.26

Percentage of individuals showing TB granuloma in a particular organ.

Table 4b

Distribution of TB granulomas in patients with miliary disseminated TB, according to age.

OrganAge (years)Total
<4040–5960–79≥80

Lungs4310219
Liver327113
Spleen137112
Kidney12508
Adrenal glands11204
Bone marrow00404
Brain11103
Small and large intestines21014
Prostate00101
Urinary bladder00101
Ovary10001
Fallopian tube10001
Uterus10001

DISCUSSION

In this 7-year study, 0.56% of all autopsies revealed signs of miliary TB that were not recognized clinically. Different autopsy studies have reported that miliary TB has accounted for from 0.3% to 13.3% of all autopsies, while miliary TB represented 11.9% to 40.5% of all cases with TB.15 We found a female predominance in clinically unrecognized TB, which is in agreement with Vasankari et al.16 A mean age above 60 years corresponds to the findings from the study of clinically unrecognized miliary TB by Rosenthal et al.17 Immunocompromised and older patients are most commonly affected.18 Our findings revealed that the most common clinical diagnoses for which miliary pulmonary TB was mistaken were exacerbation of chronic obstructive pulmonary disease and pulmonary thromboembolism, whereas miliary generalized TB clinically presented mostly as sepsis, ARDS, gastrointestinal bleeding and meningoencephalitis. They also showed hematological disturbances and were associated with different postoperative conditions. Both types of miliary TB on chest radiographs most frequently showed diffuse bilateral infiltrates of unclear etiology. Miliary TB usually has an atypical clinical presentation, which poses a significant diagnostic challenge even for experienced clinicians. Indeed, our study demonstrated that even in specialized pulmonary hospitals miliary TB may be unrecognized; still, there was a notably higher proportion of clinically unrecognized TB in general hospitals. This finding may be due to the common belief that TB incidence is drastically declining, so clinicians do not consider it in the differential diagnosis. In particular, miliary TB is usually overlooked in countries with a low incidence of TB,19 and a lack of experience with this disease may be the reason for inadequate diagnosis.20 Moreover, miliary TB may remain undiagnosed as the symptoms may be masked with previously administrated antibiotics,21 or due to atypical X-ray findings22 and an increased prevalence of extrapulmonary TB.23 However, clinicians should pay more attention to this condition, considering that individuals with unrecognized TB pose a serious risk for other patients, physicians and pathologists. This study showed the liver as the most common site of TB dissemination following the lungs in the case of miliary generalized TB. According to published data, clinical presentation of disseminated TB in the liver may be accompanied by jaundice and fever, while disseminated intravascular coagulation and multiorgan dysfunction syndrome lead to a lethal outcome in these patients.24 The spleen was the second most frequent localization of TB granulomas in our study, although published data suggests they are quite rare, especially in immunocompetent persons. They can be associated with hematological disturbances,25 as shown in our study. TB of the kidneys and urinary tract is easily overlooked given that symptoms may resemble bacterial cystitis; however, if the usual antibiotics do not help, miliary disseminated TB should be considered. High temperature, lumbar pain, hematuria and chest X-ray findings are not specific enough,26 but could suggest TB. Patients who suffer from TB often have comorbidities. For instance, patients with chronic renal failure have a 10 to 15 times higher risk of TB, predominantly due to deficiencies in the cellular immune system.27 These patients rarely show fever, while laboratory findings indicate uremia with lymphopenia.27 Uremia may be the cause of delayed hypersensitivity, decreased proliferation of Th cells and reduced phagocytic capacity of macrophages. Extrapulmonary TB is about 50% more frequent in the dialysis patients compared to general population.27 Bukhary et al previously showed that diabetes mellitus type 2 is a risk factor of TB development. Namely, patients with diabetes mellitus and TB had significantly more bacteria in sputum, positive bacterial cultures even after administration of adequate therapy, as well as more frequent resistance to anti-TB antibiotics.28 Resemblance in clinical and radiological presentation of TB and malignant tumors may lead to frequent erroneous diagnosis of these conditions. However, TB and malignancies can even coexist, as it was shown in our study. TB may be associated with an increased risk of various cancers, due to chronic inflammation and possible common risk factors, including immunosuppression and smoking.29 In conclusion, miliary TB has an atypical clinical presentation. In the case of etiologically unclear diffuse pulmonary infiltrates on chest X-ray, particularly if the patients have chronic renal failure, malignancy, hematological abnormalities (anemia, thrombocytopenia) or a history of recent surgical intervention, miliary TB should be considered. Better understanding of clinical presentation of miliary TB as well as common misdiagnoses in clinical contexts is essential for improving disease control and elimination of TB in countries facing an increased TB burden due to migrations, as well as for disease control at a global level.
  23 in total

1.  Death in notified cases of tuberculosis in Edinburgh: 1983-1992.

Authors:  C Selby; D Thomson; A G Leitch
Journal:  Respir Med       Date:  1995-05       Impact factor: 3.415

2.  Disseminated tuberculosis presenting as massive hepatosplenomegaly and hepatic failure. Case report.

Authors:  S K Sharma; S Q Shamim; C K Bannerjee; B K Sharma
Journal:  Am J Gastroenterol       Date:  1981-08       Impact factor: 10.864

3.  Undiagnosed tuberculosis in a general hospital.

Authors:  J K Ashba; J M Boyce
Journal:  Chest       Date:  1972-05       Impact factor: 9.410

4.  Undiagnosed tuberculosis in hospitalized patients--an autopsy survey.

Authors:  J K Lee; T H Ng
Journal:  J R Soc Health       Date:  1990-08

Review 5.  Acute respiratory distress syndrome (ARDS) in miliary tuberculosis: a twelve year experience.

Authors:  A Mohan; S K Sharma; J N Pande
Journal:  Indian J Chest Dis Allied Sci       Date:  1996 Jul-Sep

6.  Tuberculosis of spleen presenting with pyrexia of unknown origin in a non-immunocompromised woman.

Authors:  Prem Parkash Gupta; Sanjay Fotedar; Dipti Agarwal; Pradeep Sansanwal
Journal:  Lung India       Date:  2008-01

7.  Miliary tuberculosis in adults.

Authors:  A T Proudfoot; A J Akhtar; A C Douglas; N W Horne
Journal:  Br Med J       Date:  1969-05-03

8.  Miliary tuberculosis and adult respiratory distress syndrome.

Authors:  A R Piqueras; L Marruecos; A Artigas; C Rodriguez
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

9.  Late generalized tuberculosis: a clinical pathologic analysis and comparison of 100 cases in the preantibiotic and antibiotic eras.

Authors:  R E Slavin; T J Walsh; A D Pollack
Journal:  Medicine (Baltimore)       Date:  1980-09       Impact factor: 1.889

10.  Miliary tuberculosis presenting as fever and jaundice with hepatic failure.

Authors:  Y Asada; T Hayashi; A Sumiyoshi; M Aburaya; E Shishime
Journal:  Hum Pathol       Date:  1991-01       Impact factor: 3.466

View more
  4 in total

1.  Cryptic Disseminated Tuberculosis: a Secondary Analysis of Previous Hospital-Based Study.

Authors:  Fahmi Yousef Khan
Journal:  Tanaffos       Date:  2020-01

2.  A scoring system to effectively evaluate central nervous system tuberculosis in patients with military tuberculosis.

Authors:  Yongjiu Xiao; Shuqing Yu; Qingliang Xue; Shan Lang; Junping Sun; Dan Feng; Jianxin Wang
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

3.  All Signs Point to Cancer: A Case of Cryptic Miliary Tuberculosis in the Setting of Concomitant Cancer.

Authors:  Victoria Cress; Sue Min Sophia Kwon; Michael T Ulrich
Journal:  Case Rep Infect Dis       Date:  2021-06-04

4.  Miliary Tuberculosis Presenting with Hyponatremia and ARDS in an 82-Year-Old Immunocompetent Female.

Authors:  Benjamín Herreros; Isabel Plaza; Rebeca García; Marta Chichón; Carmen Guerrero; Emilio Pintor
Journal:  Pathogens       Date:  2018-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.